NameVinpocetine tabl. The main active ingredient vinpocetine Release form Tablets Dosage 5 mg Indications for use Neurology: the following forms of cerebral ischemia: conditions after acute cerebrovascular accident, chronic cerebrovascular insufficiency due to cerebral atherosclerosis or arterial hypertension, including vertebrobasilar insufficiency; as well as vascular dementia, post-traumatic encephalopathy. Helps to reduce mental and neurological symptoms in cerebral ischemia. Ophthalmology: for the treatment of chronic vascular pathology of the choroid (the choroid) and the retina. Otorhinolaryngology: for the treatment of sensorineural hearing loss, Meniere’s disease and idiopathic tinnitus. Dosing and Administration Vinpocetine should be prescribed 5-10 mg 3 times / day for 2 months. Apply after meals. The duration of the course of treatment is determined by the doctor, taking into account the characteristics of the disease, the effect achieved and the tolerability of the drug. Before discontinuation of the drug, the dose should be gradually reduced. Repeated courses are possible 2-3 times a year. Use during pregnancy and lactation is prohibited. Contraindications – severe cardiac arrhythmias; – ischemic heart disease (severe course); – acute period of intracerebral hemorrhage; – lactase deficiency; – increased intracranial pressure; – pregnancy; – lactation (breastfeeding); – hypersensitivity to the active substance or other components of the drug; – children under 18 years of age. Composition 1 tablet contains: active ingredient – vinpocetine 5 mg; excipients – potato starch, lactose monohydrate, microcrystalline cellulose, magnesium stearate, talc, povidone. Buy Vinpocetine tablets 5mg №10×5 Price for Vinpocetine tablets 5mg №10x5Instruction for use for Vinpocetine tablets 5mg №10×5
INN | Vinpocetine |
---|---|
The code | 2 566 |
Barcode | 4 810 201 002 439 |
Dosage | 5mg |
Active substance | Vinpocetine |
Manufacturer | Borisovsky ZMP, Belarus |
Indications Applications | Neurology: the following forms of cerebral ischemia: conditions after acute cerebrovascular accident, chronic cerebrovascular insufficiency due to cerebral atherosclerosis or arterial hypertension, including vertebrobasilar insufficiency; as well as vascular dementia, post-traumatic encephalopathy. Helps to reduce mental and neurological symptoms in cerebral ischemia. Ophthalmology: for the treatment of chronic vascular pathology of the choroid (the choroid) and the retina. Otorhinolaryngology: for the treatment of sensorineural hearing loss, Meniere's disease and idiopathic tinnitus. |
Contraindications | severe cardiac arrhythmias; – ischemic heart disease (severe course); – acute period of intracerebral hemorrhage; – lactase deficiency; – increased intracranial pressure; – pregnancy; – lactation (breastfeeding); – hypersensitivity to the active substance or other components of the drug; – children under 18 years of age. |
Use during pregnancy and lactation | Forbidden to use |
Age category | 18+ |
Application Gender | Any |
Main Active Substances | vinpocetine |
Composition Means | tablet contains: active ingredient – vinpocetine 5 mg; excipients – potato starch, lactose monohydrate, microcrystalline cellulose, magnesium stearate, talc, povidone. |
Reviews
There are no reviews yet.